This is the one where the marketing has run furthest ahead of the evidence. CoQ10 is widely sold as a blood pressure supplement on the strength of small early trials. When the Cochrane Collaboration applied its usual standards, only two trials totalling 50 participants were solid enough to pool. The result was a systolic change of -3.68 mmHg with a confidence interval running from -8.86 to +1.49, meaning the range of plausible true effects includes no effect at all. Cochrane's conclusion was direct: moderate-quality evidence that CoQ10 does not have a clinically significant effect on blood pressure. That does not make CoQ10 useless. It makes it a poor reason to buy a blood pressure supplement.
Cochrane reviews are the closest thing evidence-based medicine has to a referee. They pool the randomized trials, judge each one for risk of bias, and throw out the ones that cannot carry weight.
The 2016 update by Ho, Li and Wright looked at coenzyme Q10 for primary hypertension. Three trials met the inclusion criteria. One was judged to have an unacceptably high risk of bias and was excluded from the pooled analysis, leaving two trials and 50 participants.
Pooled, CoQ10 produced a systolic change of -3.68 mmHg (95% confidence interval -8.86 to 1.49) and a diastolic change of -2.03 mmHg (95% CI -4.86 to 0.81). Both intervals cross zero. In plain terms: given this data, a true effect of 8 mmHg and a true effect of nothing are both compatible with what was measured.
The sentence the product pages leave out. The review authors wrote that it "provides moderate-quality evidence that coenzyme Q10 does not have a clinically significant effect on blood pressure." That is not a call for more research dressed up as a maybe. It is a conclusion.
If you search for CoQ10 and blood pressure, you will find claims of reductions of 10, 15, even 17 mmHg. Those numbers trace back to early work, much of it uncontrolled or open-label, some of it in very small groups.
This is an ordinary pattern in nutrition research, not a scandal. Small, loosely controlled studies tend to produce large effects. As designs tighten, blinding improves and placebo groups get properly matched, the effect shrinks. Sometimes it survives at a smaller size, which is roughly what happened with beetroot. Sometimes it mostly disappears, which is what happened here.
The 2009 version of this same Cochrane review reached a similar place, concluding that it was uncertain whether CoQ10 reduces blood pressure. Seven years and one additional trial later, the picture did not improve.
Worth separating cleanly, because it is where CoQ10 has a genuine rationale and it is not about blood pressure.
Statins reduce cholesterol by inhibiting an enzyme early in a pathway that also produces coenzyme Q10. People taking statins do show lower circulating CoQ10, which is not disputed. The open question is whether replacing it relieves the muscle aches some people get on statins, and the trials there have been mixed rather than conclusive.
So if you are taking CoQ10 because you are on a statin and your doctor suggested trying it for muscle symptoms, that is a defensible reason with a real mechanism behind it. It is a separate matter from your blood pressure reading, and a product marketed for the second on the strength of the first is doing something slippery.
Our independent reviews go through ingredient lists, disclosed doses, and the gaps a proprietary blend leaves behind.
See Our ReviewsPlenty of people take CoQ10 for reasons that have nothing to do with this article, so the label mechanics are worth knowing.
We spend a lot of this site arguing that single-ingredient products aimed at one mechanism are a narrow bet, and that the dose has to be right for the bet to pay. CoQ10 is the case where the prior question fails first: the ingredient itself does not have the effect being sold.
That is worth saying plainly even though it is inconvenient, because a review site that only ever finds reasons to buy is not a review site. When we work through the best supplements for high blood pressure, ingredients get judged on whether the evidence holds up after someone competent squeezed it, and CoQ10 does not clear that bar for this use.
If a formula you are considering contains CoQ10 alongside other ingredients, that is not a red flag by itself. It is a reason to check what else is in there and at what dose, which is the approach we take in our review of PressureCalmX.
The Cochrane systematic review pooled the usable randomized trials and concluded there is moderate-quality evidence that coenzyme Q10 does not have a clinically significant effect on blood pressure. The pooled systolic change was -3.68 mmHg with a confidence interval spanning -8.86 to +1.49, a range that includes no effect.
Those figures come from early, mostly small and loosely controlled studies. When trials are properly blinded and placebo-controlled, the effect shrinks or disappears. Cochrane could only find two trials totalling 50 participants that met its standards, and the pooled result was not clinically significant.
That is a different question with a real mechanism behind it. Statins reduce the body's own CoQ10 production, and some people take it hoping to relieve statin-related muscle aches. The trials on that are mixed rather than settled, but the rationale is legitimate. It is not a blood pressure reason.
Ubiquinone is the oxidized form and costs less. Ubiquinol is the reduced form and is marketed as better absorbed. The body converts between them. Some studies do show better absorption for ubiquinol, though usually less than the price difference would suggest.
Trial doses commonly ranged from 100 to 200 mg a day. Capsules below that, such as 30 mg, sit under anything tested. Since CoQ10 is fat soluble, taking it with a meal containing fat matters as much as the number on the label.
CoQ10 may add a mild effect on top of antihypertensive medication, and it can reduce the effectiveness of warfarin because of its structural similarity to vitamin K. If you take warfarin or any blood pressure medication, raise it with your doctor before starting.
It is generally well tolerated. In the trials Cochrane reviewed that reported adverse effects, CoQ10 was tolerated well. Mild stomach upset, nausea and trouble sleeping are the occasional complaints, and taking it earlier in the day helps with the last one.
Not necessarily. CoQ10 inside a broader formula is not a warning sign on its own. What matters is whether the rest of the ingredients are disclosed at doses matching their research, and whether the product is being sold on a CoQ10 blood pressure claim the evidence does not support.